Ocugen Patient Engagement (@ocugenpe) 's Twitter Profile
Ocugen Patient Engagement

@ocugenpe

ID: 1645796765357182982

calendar_today11-04-2023 14:31:48

104 Tweet

510 Followers

3 Following

Ocugen Patient Engagement (@ocugenpe) 's Twitter Profile Photo
Ocugen Patient Engagement
@ocugenpe

a month ago

Today, Ocugen announced that Health Canada provided a “No Objection Letter” to initiate the OCU400 Phase 3 liMeliGhT clinical trial. Clinical sites in Canada may expedite recruitment and open doors for broader commercialization with the U.S. and Europe. bit.ly/3AE1kUl

Today, Ocugen announced that Health Canada provided a “No Objection Letter” to initiate the OCU400 Phase 3 liMeliGhT clinical trial. Clinical sites in Canada may expedite recruitment and open doors for broader commercialization with the U.S. and Europe. bit.ly/3AE1kUl